Elanco Animal Health Incorporated Number of Operating Segments
Elanco Animal Health Incorporated (ELAN) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-05
- Elanco Animal Health Incorporated number of operating segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Elanco Animal Health Incorporated number of operating segments for the quarter ending 2025-03-31 was 1.00 segment.
- Elanco Animal Health Incorporated number of operating segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Elanco Animal Health Incorporated number of operating segments for the quarter ending 2022-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Elanco Animal Health Incorporated number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- Elanco Animal Health Incorporated number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- Elanco Animal Health Incorporated number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- Elanco Animal Health Incorporated number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-25 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-26 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-01 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-28 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-05 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-07 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-01 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-28 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | 1.00 segment 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-20 | |||
| 2018-09-30 | 1.00 segment 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |